A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

Clinical trial NCT02589665 · COMPLETED

Trial details

NCT number: NCT02589665
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2015-12-09
Primary completion: 2017-12-19
Enrollment: 249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.